Intra-fraction Motion during Extreme Hypofractionated Radiotherapy of the Prostate using Pre- and Post-treatment Imaging

Clinical Oncology

Volumn 24, Issue 9, 2012, Pages 640-645

  Quon, H ^a,b   Loblaw, D A ^a,b   Cheung, P C F ^a,b   Holden, L ^b   Tang, C ^a,b   Pang, G ^a,b   Morton, G ^a,b   Mamedov, A ^b   Deabreu, A ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Image guided radiation therapy; Prostate neoplasms

Indexed keywords

ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CONTROLLED STUDY; EXTREME HYPOFRACTIONATED RADIOTHERAPY; HUMAN; LINEAR ACCELERATOR; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; RADIATION DOSE FRACTIONATION; X RAY;

FIDUCIAL MARKERS; GOLD; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL;

EID: 84866844471     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.12.001     Document Type: Article

References (31)

1. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70(1):67-74.
2. Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006, 24(13):1990-1996.
3. Zelefsky M.J., Levin E.J., Hunt M., et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70(4):1124-1129.
4. Engels B., Soete G., Verellen D., Storme G. Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers. Int J Radiat Oncol Biol Phys 2009, 74(2):388-391.
5. Kron T., Thomas J., Fox C., et al. Intra-fraction prostate displacement in radiotherapy estimated from pre- and post-treatment imaging of patients with implanted fiducial markers. Radiother Oncol 2010, 95(2):191-197.
6. Kupelian P., Willoughby T., Mahadevan A., et al. Multi-institutional clinical experience with the calypso system in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys 2007, 67(4):1088-1098.
7. Brenner D.J., Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999, 43(5):1095-1101.
8. Loblaw D.A., Cheung P. External beam irradiation for localized prostate cancer - the promise of hypofractionation. Can J Urol 2006, 13(Suppl. 1):62-66.
9. Kupelian P.A., Willoughby T.R., Reddy C.A., Klein E.A., Mahadevan A. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: cleveland clinic experience. Int J Radiat Oncol Biol Phys 2007, 68(5):1424-1430.
10. Lim T.S., Cheung P.C., Loblaw D.A., et al. Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results. Int J Radiat Oncol Biol Phys 2008, 72(1):85-92.
11. Tang C.I., Loblaw D.A., Cheung P., et al. Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3. Clin Oncol (R Coll Radiol) 2008, 20(10):729-737.
12. Cheung P., Sixel K., Morton G., et al. Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer. Int J Radiat Oncol Biol Phys 2005, 62(2):418-425.
13. Aubin S., Beaulieu L., Pouliot S., et al. Robustness and precision of an automatic marker detection algorithm for online prostate daily targeting using a standard V-EPID. Med Phys 2003, 30(7):1825-1832.
14. van Herk M., Remeijer P., Rasch C., Lebesque J.V. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000, 47(4):1121-1135.
15. Kotte A.N., Hofman P., Lagendijk J.J., van Vulpen M., van der Heide U.A. Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers. Int J Radiat Oncol Biol Phys 2007, 69(2):419-425.
16. Ghilezan M.J., Jaffray D.A., Siewerdsen J.H., et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 2005, 62(2):406-417.
17. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys 2008, 35(1):310-317.
18. Noel C., Parikh P.J., Roy M., et al. Prediction of intrafraction prostate motion: accuracy of pre- and post-treatment imaging and intermittent imaging. Int J Radiat Oncol Biol Phys 2009, 73(3):692-698.
19. Patel R.R., Orton N., Tome W.A., Chappell R., Ritter M.A. Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer. Radiother Oncol 2003, 67(3):285-294.
20. Teh B.S., Dong L., McGary J.E., Mai W.Y., Grant W., Butler E.B. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer. Med Dosim 2005, 30(1):25-30.
21. Teh B.S., McGary J.E., Dong L., et al. The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device?. Cancer J 2002, 8(6):476-483.
22. van Lin E.N., Kristinsson J., Philippens M.E., et al. Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy. Int J Radiat Oncol Biol Phys 2007, 67(3):799-811.
23. Li J.S., Jin L., Pollack A., et al. Gains from real-time tracking of prostate motion during external beam radiation therapy. Int J Radiat Oncol Biol Phys 2009, 75(5):1613-1620.
24. Madsen B.L., Hsi R.A., Pham H.T., Fowler J.F., Esagui L., Corman J. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys 2007, 67(4):1099-1105.
25. King C.R., Brooks J.D., Gill H., Pawlicki T., Cotrutz C., Presti J.C. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys 2009, 73(4):1043-1048.
26. Boike T.P., Cho L., Lotan Y., et al. A phase I dose escalation study of stereotactic body radiation therapy (SBRT) for low- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 2009, 75(3):S80.
27. Kupelian P.A., Willoughby T.R., Meeks S.L., et al. Intraprostatic fiducials for localization of the prostate gland: monitoring intermarker distances during radiation therapy to test for marker stability. Int J Radiat Oncol Biol Phys 2005, 62(5):1291-1296.
28. Delouya G., Carrier J.F., Beliveau-Nadeau D., Donath D., Taussky D. Migration of intraprostatic fiducial markers and its influence on the matching quality in external beam radiation therapy for prostate cancer. Radiother Oncol 2010, Jul;96(1):43-47.
29. Nichol A.M., Brock K.K., Lockwood G.A., et al. A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers. Int J Radiat Oncol Biol Phys 2007, 67(1):48-56.
30. Mutanga T.F., de Boer H.C., van der Wielen G.J., et al. Margin evaluation in the presence of deformation, rotation, and translation in prostate and entire seminal vesicle irradiation with daily marker-based setup corrections. Int J Radiat Oncol Biol Phys 2010, Nov 15;81(4):1160-1167.
31. Peng C., Ahunbay E., Chen G., et al. Characterizing interfraction variations and their dosimetric effects in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2011, 79(3):909-914.